Das Hanusch-Krankenhaus befindet sich im 14. Wiener Gemeindebezirk in der Heinrich-Collin-Straße 30. Es ist ein Krankenhaus mit zehn Abteilungen und sieben Instituten, darunter das Ludwig-Boltzmann-Institut, ein Forschungsinstitut für Osteologie und Leukämie-Forschung.

During the past decade, AT-Vienna-HANUSCH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AT-Vienna-HANUSCH" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "European Myeloma Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "AT-Vienna-HANUSCH" are "Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "AT-Vienna-HANUSCH" in a lesser frequency.

Most popular intervention types in "AT-Vienna-HANUSCH" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "AG-120" (1 trials), "AG-221" (1 trials) and "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "AT-Vienna-HANUSCH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "AT-Vienna-HANUSCH". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AT-Vienna-HANUSCH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AT-Vienna-HANUSCH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".